Blackstone in Record $6.3 Billion Blackstone Life Sciences VI

Cleary Gottlieb represented Blackstone in connection with the formation of Blackstone Life Sciences VI (BXLS VI), which held its final closing on March 27, 2026.

BXLS VI, the largest private fund dedicated to life sciences, was oversubscribed and closed at its hard cap with $6.3 billion of total capital commitments, nearly 40% larger than its predecessor vehicle, on which Cleary also advised.

Blackstone Life Sciences (BXLS) is a leading private investment platform with capabilities to invest across the life cycle of companies and products within the key life science sectors.

The Cleary global funds team includes partners Maurice Gindi and Emily Alfano; associates Kate Torrey, Damien Chang, Sean Milligan, Myles Ambrose, and Yue (Wendy) Wu; and law clerk Jacqueline Albury. The tax team includes partner Meyer Fedida and associates Michael Eis and Mingyu Tang. Partner Liz Dyer advised on ERISA matters. Partners Amy Shapiro and Anna Kogan advised on finance matters. Partners Chase Kaniecki and Samuel Chang and associate B.J. Altvater advised on CFIUS and OIR matters. Partner Michael Sanders advised on AML matters. Partner Jens Hafemann and associate Jonathan Seebach advised on German tax matters. Partner Amber Phillips and senior counsel Robin Bergen advised on Advisers Act matters. Senior corporate staff attorneys Vilma Preta and Yvonne Dompierre, tax attorney Christine Shin, and corporate staff attorney Anushka Nicholas provided subscription document review assistance. Counsel Elizabeth Chang advised on Blue Sky matters.